Moderna
A Senior LIMS Systems Expert at Moderna shapes the strategic vision for the Quality Control Digital roadmap and implements new LabVantage solutions. The role involves leading continuous improvement projects, collaborating with cross-functional teams, and providing application support as a Level 2/3 SME in a GxP environment.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2010
Moderna is a biotechnology company that is pioneering the use of mRNA technology to develop transformative medicines and vaccines. It gained global prominence for its COVID-19 vaccine, which showcased the potential of mRNA in rapidly addressing public health emergencies. The company is focused on creating innovative therapies to treat a range of diseases, advancing its product pipeline, and exploring new career opportunities in the biotech field. With a commitment to changing the landscape of medicine, Moderna is at the forefront of scientific research and development.
Moderna | History, Innovation, Challenges, & Facts | Britannica Money
5 days ago
An Erratic FDA Is a Threat to Innovation
5 hours ago
Moderna, Inc. $MRNA Position Increased by Theleme Partners LLP
2 hours ago
Moderna operates through several specialized therapeutic “pillars”:
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Moderna.
37% above the average for this role
6 hours ago
6338 - LabVantage LIMS Instrument Integration SME / Lead Validation Engineer
Verista, Inc.
Lead Engineer LIMS - LabVantage
PDDN INC.
Senior/Lead Technical Project Manager - Global LIMS
Novo Nordisk A/S
LabVantage LIMS Support Engineer
Capgemitecp3
Lead LIMS Engineer
Capgemitecp3
LabVantage LIMS Developer - BioBanking
Novo Nordisk A/S